Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Systematic review of hepatic arterial infusion chemotherapy versus sorafenib in patients with hepatocellular carcinoma with portal vein tumor thrombosis
Miao Liu, Junyi Shi, Tong Mou, et al.
Journal of Gastroenterology and Hepatology (2020) Vol. 35, Iss. 8, pp. 1277-1287
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
Hideki Iwamoto, Shigeo Shimose, Tomotake Shirono, et al.
Clinical and Molecular Hepatology (2023) Vol. 29, Iss. 3, pp. 593-604
Open Access | Times Cited: 36
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Jie Mei, Shaohua Li, QiJiong Li, et al.
Journal of Hepatocellular Carcinoma (2021) Vol. Volume 8, pp. 167-176
Open Access | Times Cited: 49
The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
Fangzhou Luo, Mengxia Li, Jun Ding, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 42
Management of hepatocellular carcinoma patients with portal vein tumor thrombosis: A narrative review
Ziwen Tao, Baoquan Cheng, Tao Zhou, et al.
Hepatobiliary & pancreatic diseases international (2021) Vol. 21, Iss. 2, pp. 134-144
Closed Access | Times Cited: 42
A Phase I Study of Locoregional High-Dose Autologous Natural Killer Cell Therapy With Hepatic Arterial Infusion Chemotherapy in Patients With Locally Advanced Hepatocellular Carcinoma
Woo Kyun Bae, Byung-Chan Lee, Hyeon-Jong Kim, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Immunotherapy of hepatocellular carcinoma: recent progress and new strategy
Jiarui Li, Shihai Xuan, Peng Dong, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review
Wei Zhang, Deliang Ouyang, Zhangkan Huang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 14
Hepatic Arterial Infusion of Chemotherapy for Advanced Hepatobiliary Cancers: State of the Art
Carmelo Laface, Mariarita Laforgia, P. Molinari, et al.
Cancers (2021) Vol. 13, Iss. 12, pp. 3091-3091
Open Access | Times Cited: 29
Management strategies for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Jeayeon Park, Su Jong Yu
The Ewha Medical Journal (2025) Vol. 48, Iss. 1
Open Access
Radiotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors combined with hepatic arterial infusion chemotherapy of RALOX versus FOLFOX for hepatocellular carcinoma with portal vein tumor thrombus: a propensity score-matching cohort study
Hao-Yang Tan, Shuangquan Liu, Yanhan Liu, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
The clinical characteristics and prognostic factors of combined Hepatocellular Carcinoma and Cholangiocarcinoma, Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma after Surgical Resection: A propensity score matching analysis
Youyin Tang, Lingyan Wang, Fei Teng, et al.
International Journal of Medical Sciences (2020) Vol. 18, Iss. 1, pp. 187-198
Open Access | Times Cited: 25
Portal vein tumor thrombosis in hepatocellular carcinoma: molecular mechanism and therapy
Xing-Hao Zhou, Jingru Li, Tang‐Hui Zheng, et al.
Clinical & Experimental Metastasis (2022) Vol. 40, Iss. 1, pp. 5-32
Closed Access | Times Cited: 15
Conversion therapy for advanced hepatocellular carcinoma with vascular invasion: a comprehensive review
Zunyi Zhang, Erlei Zhang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Hepatic artery infusion chemotherapy combined with the FOLFOX regimen for the treatment of hepatocellular carcinoma: recent advances and literature review
Suqi Zhu, Yahan Yu, Mingqi Yang, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 6, pp. 423-434
Closed Access | Times Cited: 3
Getting Chemotherapy Directly to the Liver: The Historical Evolution of Hepatic Artery Chemotherapy
Roi Anteby, Nancy E. Kemeny, T. Peter Kingham, et al.
Journal of the American College of Surgeons (2020) Vol. 232, Iss. 3, pp. 332-338
Open Access | Times Cited: 22
A preliminary study of optimal treatment response rates in patients undergoing hepatic arterial infusion chemotherapy combined with molecular targeting and immunotherapy
Mei Li, Jun Liao, Li Wang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Neoadjuvant radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: a systematic review
Zhewen Wei, Jianjun Zhao, Xinyu Bi, et al.
HepatoBiliary Surgery and Nutrition (2021) Vol. 11, Iss. 5, pp. 709-717
Open Access | Times Cited: 15
Management of Systemic Therapies and Hepatic Arterial Infusion Chemotherapy in Patients with Advanced Hepatocellular Carcinoma Based on Sarcopenia Assessment
Takahiro Yamasaki, Issei Saeki, Yurika Yamauchi, et al.
Liver Cancer (2022) Vol. 11, Iss. 4, pp. 329-340
Open Access | Times Cited: 11
Analysis on Efficacy of Hepatic Artery Infusion Chemotherapy with or without Lenvatinib for Unresectable Hepatocellular Carcinoma
Wei Yuan, Wenchao Yue, Huabing Wen, et al.
European Surgical Research (2023) Vol. 64, Iss. 2, pp. 268-277
Open Access | Times Cited: 6
Meta-Analysis of Postoperative Adjuvant Hepatic Artery Infusion Chemotherapy Versus Surgical Resection Alone for Hepatocellular Carcinoma
Qiao Ke, Lei Wang, Weimin Wu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 14
Liver-Directed Concurrent Chemoradiotherapy versus Sorafenib in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
Jina Kim, Hwa Kyung Byun, Tae Hyung Kim, et al.
Cancers (2022) Vol. 14, Iss. 10, pp. 2396-2396
Open Access | Times Cited: 10
Prognostic nomogram predicting survival of patients with unresectable hepatocellular carcinoma after hepatic arterial infusion chemotherapy
Jie Mei, Wen‐Ping Lin, Feng Shi, et al.
European Journal of Radiology (2021) Vol. 142, pp. 109890-109890
Open Access | Times Cited: 11
The Clinical Impact of Hepatic Arterial Infusion Chemotherapy New-FP for Hepatocellular Carcinoma with Preserved Liver Function
Hideki Iwamoto, Takashi Niizeki, Hiroaki Nagamatsu, et al.
Cancers (2022) Vol. 14, Iss. 19, pp. 4873-4873
Open Access | Times Cited: 7
Hepatic arterial infusion chemotherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: exploring the influence of prior transarterial chemoembolization and additional transarterial chemoembolization on survival outcomes
Phan Nhan Hien, Ho Jong Chun, Jung Suk Oh, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 2, pp. 721-729
Open Access | Times Cited: 1
Stereotactic body radiotherapy versus lenvatinib for hepatocellular carcinoma with portal vein tumor thrombosis: a propensity matching score analysis
Xiaoquan Ji, Aimin Zhang, Xuezhang Duan, et al.
Radiation Oncology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top